Show simple item record

dc.contributor.authorPlessis, Stefan S. du
dc.date.accessioned2021-11-28T11:26:08Z
dc.date.available2021-11-28T11:26:08Z
dc.date.issued2020
dc.identifier.other204-2020.105
dc.identifier.urihttps://repository.mbru.ac.ae/handle/1/609
dc.description.abstractAbstract: Advanced glycation end products (AGEs) are products of cascades of non-enzymatic glycosylation. They are formed over a period of hours to days, depending on the protein lifetime. AGEs acts by independently producing reactive oxygen species (ROS) or by binding to their receptors. Binding of AGE to the receptor for advanced glycation end products (RAGE) has been shown to play a role in physiological processes, including lung homeostasis, bone metabolism, neuronal systems and the immune system. When in excess, they take part in the pathogenesis of diseases such as diabetes mellitus, cardiovascular diseases, neurodegenerative diseases, and etcetera. The cause of male infertility is considered unexplained in many cases, suggesting that there are gaps in the mechanistic knowledge of sperm production and function, especially, pathways involved in the physiochemical protein regulation of spermatogenesis. It is therefore important to consider areas of research highlighting protein modification and identification and their implication for male fertility.en_US
dc.language.isoenen_US
dc.subjectAdvanced glycation end productsen_US
dc.subjectReceptor for advanced glycation end productsen_US
dc.subjectHyperglycaemiaen_US
dc.subjectMale infertilityen_US
dc.subjectInfertilityen_US
dc.subjectAssisted reproductive technologyen_US
dc.titleMale infertility: A proximate look at the advanced glycation end productsen_US
dc.typeArticleen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record